CHANDRA SEKHAR PASULA et al. 2019. Effect of quercetin and prima-1MET (P53 activator) combination therapy on P53 mutant type human colon cancer cells (COLO-320). International Journal of Pharma and Bio Sciences. 10, 1 (Mar. 2019), 61–67. DOI:https://doi.org/10.22376/ijpbs.2019.10.1.p61-67.